Unicycive Therapeutics, Inc.UNCYNASDAQ
LOADING
|||
Switch Symbol:
Net Income Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year net income growth rate
Latest
6.76%
↑ 107% above average
Average (26q)
-91.22%
Historical baseline
Range
High:147.01%
Low:-1231.05%
Volatility
-1510.7%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | 6.76% |
| Q2 2025 | -1231.05% |
| Q1 2025 | 102.65% |
| Q4 2024 | -425.51% |
| Q3 2024 | -141.56% |
| Q2 2024 | 147.01% |
| Q1 2024 | -168.83% |
| Q4 2023 | -79.97% |
| Q3 2023 | -12.90% |
| Q2 2023 | 73.67% |
| Q1 2023 | -173.55% |
| Q4 2022 | 4.12% |
| Q3 2022 | -52.83% |
| Q2 2022 | -2.80% |
| Q1 2022 | -28.52% |
| Q4 2021 | 47.09% |
| Q3 2021 | -372.82% |
| Q2 2021 | -14.11% |
| Q1 2021 | -9.55% |
| Q4 2020 | -25.36% |
| Q3 2020 | -107.69% |
| Q2 2020 | 1.74% |
| Q1 2020 | 51.00% |
| Q4 2019 | -24.47% |
| Q3 2019 | -25.47% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |